The Division of Rheumatology at Albert Einstein College of Medicine has a long and distinguished history of accomplishments that has helped elucidate our current understanding of rheumatologic disease. This includes participating in some of the earliest studies on impaired immunity in systemic lupus erythematosus (SLE); establishing one of the first immunodiagnostic laboratories in the nation; and conducting innovative research on the pathophysiology of neuropsychiatric lupus. Our research extends to studying the risks and benefits of hydroxychloroquine in lupus and the psychosocial factors affecting patients with rheumatologic disease. Our diverse patient population with its broad spectrum of diseases motivates us to continue to search for answers in the laboratory, clinic, and the community.

Clinical Trials and Registries

We are relentlessly investigating Systemic Lupus Erythematosus disease manifestations and clues to their root causes, identify and validate diagnostic markers, and evaluate new therapeutics; all with a direct impact on the lives of Lupus patients. To that end, we are actively recruiting interested patients to disease registries, as well as clinical and pharmaceutical trials

Learn More

Putterman Lab

The Putterman Lab is a leader in the field of immunology and autoimmunity, specifically in its study of systemic lupus erythematosus. Its focus is on the identification and characterization of novel mechanisms, biomarkers and treatment approaches to immune-mediated nephritis, neuropsychiatric lupus, and systemic lupus erythematosus.

Learn More